🇺🇸 US Stock Screener ← Switch market ⚡ HerAI

SRX Global Inc. SRXH

Consumer Defensive · Packaged Foods · United States
https://www.srxglobalinc.com
Company Profile ↓
$1.58
-90.97% 1Y
Mkt Cap$32.02M
P/E0.02
P/B0.23
52W High$34.11
52W Low$1.32
Book Value$7.16
EPS (TTM)$68.20

Company Overview

SRX Global Inc. operates an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. It leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across various sectors. The company is based in Tampa, Florida.

Why Investors Should Care

Reasonable Valuation

Trades at a P/E of 0.0, below the sector median of 18.6.

Recent Developments

  • Sep 2025 Revenue of $6.53M (-81.3% YoY); net profit $-45.01M.
  • Trailing 12 Months Year-on-year growth — revenue -81.3%.
  • 5-Year Trend Long-term compounding — revenue CAGR -32.3%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-32.32%
1 Year:-81.32%

Stock Price Performance

1 Year:-90.97%
6 Months:-78.05%
3 Months:-78.40%
1 Month:-0.63%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 1% of range
$1.32 $34.11
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)37.40 · Neutral
Price Performance
1M-0.63%
3M-78.40%
6M-78.05%
1Y-90.97%
Valuation vs Sector

P/E of 0.02 is below the sector median of 18.56 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Revenue declined at -32.3% CAGR over 5 years.
  • Trading 95.4% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
0.02
Industry PE
18.56
Forward P/E est.
0.04
PEG Ratio
-
Book Value
$7.16
Price to Book
0.23
P/S
4.75
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-32.32%
Profit 5Y
-
Revenue (YoY)
-81.32%
Earnings (YoY)
-

Profitability & Returns

ROCE
-
ROE
-
ROA
-
Profit Margin
0.00%
Op Margin
-94.37%
Gross Margin
0.00%
EPS (Latest Qtr)
$-1.20
EPS (TTM)
$68.20

Balance Sheet & Liquidity

Debt/Equity
10.99
Quick Ratio
0.00
Current Ratio
0.00
Debt
$0
Total Assets
$43.36M
Current Assets
$43.15M
Working Capital
$4.58M

Ownership

Promoter Holding
1.95%
Chg in Prom Hold
0.06%
FII / Inst Holding
4.07%
Chg in FII Hold
0.12%

Financial Snapshot

Enterprise Value
$32.02M
Total Revenue (TTM)
$6.53M
EBITDA
$-7.98M
Free Cash Flow
$-10.22M
Operating Cash Flow
$0
Shares Outstanding
20.27M
Gross Margin
0.00%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 SRXH SRX Global Inc. 1.58 0.02 $32.02M 0.00% - - -32.32% -
2 WMT Walmart Inc. SPXR3K 107.14 38.82 $850.02B 0.93% 16.83% 22.31% 3.82% 3.24%
3 COST Costco Wholesale Corporation NDXSPXR3K 910.18 45.88 $403.65B 0.65% 25.96% 29.15% 8.16% 11.45%
4 KO The Coca-Cola Company SPXR3K 88.36 26.53 $380.17B 2.41% 16.47% 42.05% 2.86% 4.46%
5 PG The Procter & Gamble Company SPXR3K 145.58 21.99 $338.39B 2.95% 22.49% 30.29% 0.52% 1.59%
6 PM Philip Morris International Inc. SPXR3K 184.73 25.37 $287.92B 3.09% 34.03% -113.55% -1.69% 3.57%
7 PEP PepsiCo, Inc. NDXSPXR3K 138.45 18.15 $189.12B 4.43% 15.41% 51.51% 4.93% 2.11%
8 BUD Anheuser-Busch InBev SA/NV 79.73 17.18 $139.30B 1.69% 8.49% 11.39% 0.88% 4.63%
9 BTI British American Tobacco p.l.c. 55.15 14.18 $118.73B 5.98% 12.44% 13.42% -2.53% 5.21%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Feb 2015May 2015Nov 2015Feb 2016May 2016Nov 2016Feb 2017May 2017Nov 2017Feb 2018Mar 2018May 2018Jun 2018Sep 2018Nov 2018Feb 2019Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ------------3.82M3.98M--3.55M4.08M3.93M12.23M9.94M11.13M10.83M10.99M13.20M17.01M16.52M11.87M9.24M10.54M13.12M7.90M42.67M11.37M07.16M--34.55M2.81M3.44M
Cost of Revenue ----------------------------------04.78M--25.78M1.75M2.16M
Gross Profit -------57618777-02.43M1.52M001.89M1.66M836.00K4.16M4.12M4.46M4.28M3.90M4.44M4.71M4.73M4.17M3.24M3.59M4.44M2.61M9.42M4.52M02.38M--8.77M1.05M1.27M
Operating Expenses ----------------------------------03.47M--26.85M4.84M3.09M
Operating Income -11.00K-5.82K-16.43K-7.48K-283.18K-83.93K-221.45K-114.98K-85.06K-66.40K--239.51K-702.00K-1.41M-147.52K-388.90K-2.71M-11.26M-9.68M-8.53M-12.50M-3.28M-5.14M-3.20M-3.97M-3.96M-4.26M-6.40M-3.25M-2.58M-2.62M-2.47M-1.32M-1.13M0-1.09M-18.08M-3.79M-1.82M
EBITDA ----------------------------------920.00K-1.06M-21.48M-7.31M-4.60M
Interest Expense ----------------------------------0---1.29M1.78M
Pretax Income ----------------------------------0-962.00K-21.74M-8.61M-6.38M
Tax Provision ----------------------------------02.00K-630.00K4.00K2.00K
Net Income -18.75K-11.91K-18.69K-7.49K-464.48K-200.56K-755.15K-465.67K-110.70K-951.49K-1.66M-18.02M-745.00K-1.44M502.22K-166.06K-2.78M-161.51M-6.03M-9.45M-18.40M-1.69M-12.85M24.78M-3.46M-4.04M-4.37M-6.55M-3.48M-2.96M-1.62M-2.83M-3.12M1.53M-3.98M-964.00K--15.26M-8.61M-6.38M
Diluted EPS 0.000.000.000.00-0.000.00-0.01-0.010.00-0.31----0.00-0.09-----2.26-0.21-1.381.19-0.12-0.14-0.15-0.22-5.03-4.27-2.30-3.60-0.140.73-0.28-0.07-44.40--0.09-1.20
R&D Expense -------------0---0----------------------

Profit & Loss (Annual)

Figures in USD.

Metric Aug 2001Aug 2002Aug 2003Aug 2004Aug 2005Aug 2006Aug 2007Aug 2008Aug 2009Aug 2010Aug 2011Aug 2012Aug 2013Aug 2014Aug 2015Aug 2016Aug 2017Aug 2018Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Sep 2024Dec 2024Sep 2025
Revenue ----------00000481.73K47514.79M15.58M42.59M46.01M54.66M38.59M034.98M6.53M
Cost of Revenue ------------------------0-5.01M
Gross Profit ----------------1.40K2647.30M5.86M16.11M15.37M15.26M11.80M012.99M1.53M
Operating Expenses ------------------------0-12.93M
Operating Income -----------39.23K-13.22K-22.08K-27.27K-24.65K-459.68K-524.04K-527.89K-5.16M-36.33M-27.32M-17.28M-38.78M-21.18M0-5.97M-11.41M
EBITDA ------------------------4.39M--7.98M
Interest Expense ------------------------0-628.00K
Pretax Income ------------------------0--8.64M
Tax Provision ------------------------0-0
Net Income -16.20K-125.00K0000000-38.42K-40.85K-15.91K-94.17K-51.24K-49.67K-933.76K-1.74M-2.95M-6.03M-184.46M-59.34M3.39M-39.32M-22.77M-43.05M-168.00K-45.01M
Diluted EPS -----------0.68-0.26-1.560.000.00-0.01-0.02----7.260.14-58.93-32.29-3.01-0.10-1.81
R&D Expense --------------------100.00K500.00K500.00K100.00K-100.00K-

Balance Sheet (Annual)

Figures in USD.

Metric Jan 2001Aug 2009Aug 2010Aug 2011Aug 2012Aug 2013Aug 2014Aug 2015Aug 2016Aug 2017Dec 2017Aug 2018Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Sep 2023Dec 2023Sep 2024Dec 2024Sep 2025
Total Assets ---16.99K12.80K8.57K4.38K2.19K16.64K16.32K-209.08K5.99M53.53M51.25M74.66M38.68M-16.74M33.76M15.80M8.40M
Current Assets -------------------13.64M-8.13M
Cash & Equivalents 0-59373800010.20K1.44K-199.67K3.95M2.36M3.93M21.73M3.17M-4.46M106.00K3.07M1.31M
Inventory -------------------3.37M-2.08M
Receivables -------------------9.28M-3.94M
Total Liabilities ------------9.03M50.04M79.36M16.79M17.15M-13.76M88.88M7.15M8.00M
Current Liabilities ---56.94K68.66K89.36K37.40K59.87K590.96K1.20M-2.86M9.03M33.03M54.58M7.34M5.58M-13.69M81.30M7.15M3.54M
Long Term Debt ---------0-06.20M16.37M24.59M9.41M11.44M-4.62M696.00K2.41M4.45M
Total Debt -------------------45.31M-4.47M
Total Equity -30.34K899-39.95K-55.86K-80.79K-33.02K-2.40M-574.32K-1.18M-2.12M-2.65M-3.04M-7.07M-28.10M57.88M21.53M-33.78M2.98M-55.12M8.65M407.00K
Shares Outstanding -------------------14.30M-24.92M

Cash Flows (Annual)

Figures in USD.

Metric Aug 2011Aug 2012Aug 2013Aug 2014Aug 2015Aug 2016Aug 2017Aug 2018Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Sep 2024Dec 2024Sep 2025
Operating Cash Flow -18.38K-17.74K-17.19K-22.62K-22.88K-180.60K-39.76K--6.90M-20.97M-7.50M-11.86M-20.55M97.00K-1.48M-4.36M-8.14M
Investing Cash Flow 00000-250.00K00-31.00K-20.21M-151.00K-353.00K-198.00K-18.00K-1.09M-2.25M5.91M
Financing Cash Flow 18.36K17.74K17.15K22.62K22.88K440.80K31.00K-10.72M39.76M9.11M37.16M1.28M-5.10M932.00K5.22M12.17M
Capital Expenditure ---------31.00K-110.00K-151.00K-353.00K-198.00K-18.00K--41.00K-2.08M
Free Cash Flow ---------6.93M-21.08M-7.66M-12.21M-20.75M79.00K-1.48M-4.40M-10.22M
Net Change in Cash ---------------1.64M-1.41M
Share Buybacks ----------01.60M0----

Ratios (Annual)

Figures in %.

Metric Aug 2001Aug 2002Aug 2003Aug 2004Aug 2005Aug 2006Aug 2007Aug 2008Aug 2009Aug 2010Aug 2011Aug 2012Aug 2013Aug 2014Aug 2015Aug 2016Aug 2017Aug 2018Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Sep 2024Dec 2024Sep 2025
Gross Margin % ----------------80.7%55.6%49.3%37.6%37.8%33.4%27.9%30.6%-37.1%23.4%
Operating Margin % ----------------957,670.8%-30,221.3%-111,134.1%-34.9%-233.2%-64.2%-37.6%-71.0%-54.9%--17.1%-174.6%
Net Margin % ----------------1,945,335.4%-100,533.9%-621,225.1%-40.8%-1,184.2%-139.3%7.4%-71.9%-59.0%--0.5%-688.8%
ROE % --------0.0%-4,273.7%102.3%28.5%116.6%155.2%2.1%162.6%147.4%111.4%198.1%2,608.7%211.1%5.9%-182.6%-764.6%78.1%-1.9%-11,058.0%
ROCE % ----------98.2%23.7%27.3%82.6%42.7%80.0%44.3%19.9%169.6%-177.1%822.2%-25.7%-117.2%-695.5%-0.0%-69.0%-234.7%

Shareholding Pattern

Insiders
1.95%
Institutions
4.07%
Public Float
4.15%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 0.76% 154.47K $257.96K
2 Geode Capital Management, LLC 0.58% 116.57K $194.67K
3 Vanguard Capital Management LLC 0.57% 116.16K $193.98K
4 Citadel Advisors Llc 0.50% 101.00K $168.67K
5 Renaissance Technologies, LLC 0.40% 81.02K $135.30K
6 SBI Securities Co., Ltd. 0.28% 56.58K $94.50K
7 State Street Corporation 0.28% 55.99K $93.50K
8 Jane Street Group, LLC 0.28% 56.33K $94.07K
9 Vanguard Fiduciary Trust Co 0.26% 53.66K $89.61K
10 Northern Trust Corporation 0.11% 22.00K $36.75K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SRXH

Google News Sun, 06 Sep 2026

SRXH Stock Climbed 15% Today — What’s Driving The Rally? - Stocktwits

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQdC1JVEtqN0hVVlptYzJlREJsMUVNRVJPUjM1QUJTWUhiaWJUNVhYLTluQy1GRWg0c1hjakh3czgtMGJtdzZwQUtsLVVxczVIT084WWlPZ1ZxS2NVUTBnaWdCa1VkWTcxSkxSRjFJWHZ2eFdkMFhOeEVZQUdzWkVxelliQVJCQnRZTmFzdE…

Google News hu, 03 Sep 2026

A fentanyl vaccine produced an immune response in humans. ARMR is testing doses. - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOS0V6c1B4ZjY5bXgyT1NENmlFaFMtMzhjak1zT3Z0VXJLVXRyblBXOGdzUlFwaUtBcVFHRlVnYjdxM3hvdWtBMjFDZzlFU0dWQUZ0TXVKUjMxNXI5Vk5tVk5FY001eVJJOElHVG9CbGY5MlFvbmVONXFhd0pBVG8tdTI5MUNHWF8zM2ZqRF…

Google News Wed, 24 Jun 2026

SRXH Stock Crashed 20% Today – What’s Dampening Investors' Mood? - finance.yahoo.com

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNZmRfYXVwWjBxd1REU1pjMWNUZm9iQWlZXzVaNHpneXdpTGVTd3JaMlR1RzRxaWs1d0QxODY0dFdXT2Z5bmtTZVROVXJEVUwyazJYc3ZIOUU1bVFQQVV4enFJbWp4aTJtM3RiMFlkS2o5b1JsdmJjM2RmQTFjY0NvWW5KMnRvTjRZcDBQTU…

Google News ue, 14 Jul 2026

SRXH Stock Falls Premarket Ahead Of Eric Jackson's Fireside Chat — Traders Brace For Buyback Clues And CEO Spotlight - TradingView

<a href="https://news.google.com/rss/articles/CBMihAJBVV95cUxOYVBzR2FIclRQQWZaSllfVVBkQ3U5eUhrSS1XNFNCSG5naGRYY0t1R3Z4b2szOTB6MjhjNXRTaUhMU0RqWkhYT0NDNGdyQk8xQ2RQMmFKRW9xSzZBeFNBT09pZFAtcWtrZzk0RDVIU0RoQVRHRTFKOFZrWXY3eE56cDFuSHRZUHlpSkJFQU…

Google News Wed, 24 Jun 2026

SRX Global Approves 60-to-1 Stock Consolidation Effective July 6, 2026 | SRXH Stock News - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNZU96Yy1UU3hucUM1THdSeldDTXZmcUhRWU5kVmlQRnlQRUJUUC1SR0VaVEItVDZYRkNHQzFpaWNHMEZkaVFXa09LSjNTVVBZX3dteXZPMzBVQU5mNVVDWm4wZ0RzSVNnUnRHUHRfbU0zbWNMMWgxVnlwWkc4bHFhQUNudzBxRkpFX0hBdT…

Google News hu, 03 Sep 2026

SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company - markets.businessinsider.com

<a href="https://news.google.com/rss/articles/CBMi_AFBVV95cUxOYzJZQUl4V3JoRHRwLUFWQzdDR2w5WGVZOXFBa1JncEd0c2dvSThraTh5ZU8yMDhYZ0hDaXBoVUJ6UDZReFplNXZSZExwYi1VUjZzRTd0T2hCWFgwVE5kcGdVMThlOGVGbVNCLUhydExGdWNKSldEYU1TcFdBQml2U0x4VTFlQ2UyeC1rNn…

SRXH — Frequently Asked Questions

What is the current share price of SRX Global Inc. (SRXH)?

As of 2026-09-19 21:16 PDT, SRX Global Inc. (SRXH) trades at $1.58 on NYSE American. Its 52-week range is $1.32 to $34.11.

What is the market capitalisation of SRXH?

SRX Global Inc. (SRXH) has a market capitalisation of $32.02M on NYSE American.

What is the P/E ratio of SRXH?

SRXH trades at a trailing price-to-earnings (P/E) ratio of 0.02. The industry average P/E is 18.56. Its price-to-book (P/B) ratio is 0.23.

Is SRXH a good stock to buy?

This page provides a data-driven analysis of SRX Global Inc. (SRXH), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Consumer Defensive Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space